---
category: disclosure
circular_id: f1fe5e80ebde87b6
date: '2025-07-31'
description: Open offer by Shankarappa Nagaraja Vinaya Babu to acquire up to 26% stake
  in Pharmaids Pharmaceuticals Limited at ₹62.15 per share.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={7DF9AC2B-FE5D-45B0-90A5-B837F1EC7E07}&noticeno=20250731-50&dt=07/31/2025&icount=50&totcount=57&flag=0
impact: high
impact_ranking: high
importance_ranking: high
justification: Major takeover offer affecting 26% of company shares with mandatory
  regulatory disclosure
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250731-50&attachedId=5052dda9-36a4-4fdb-b6a2-240163837f47
processing:
  attempts: 1
  content_hash: 48d87d10f63cb28c
  processed_at: '2025-07-31T15:25:46.301553'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-07-31T14:35:03+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={7DF9AC2B-FE5D-45B0-90A5-B837F1EC7E07}&noticeno=20250731-50&dt=07/31/2025&icount=50&totcount=57&flag=0
severity: high
source: bse
stocks:
- PHARMAIDS
tags:
- sast
- takeover
title: Opening of Offer to Buy – Acquisition Window (Takeover) of PHARMAIDS PHARMACEUTICALS
  LIMITED
---

## Summary

Shankarappa Nagaraja Vinaya Babu, along with Person Acting in Concert (PAC) Tumkur Trade Center Private Limited, has made an open offer to acquire up to 91,69,632 equity shares (26% stake) of Pharmaids Pharmaceuticals Limited at ₹62.15 per share. This mandatory offer is being made pursuant to SEBI (SAST) Regulations, 2011 following an underlying transaction.

## Key Points

- Offer to acquire 91,69,632 equity shares representing 26% of total voting share capital
- Offer price: ₹62.15 per equity share of face value ₹10 each
- Target Company: Pharmaids Pharmaceuticals Limited (CIN: L52520KA1989PLC173979)
- Acquirer: Shankarappa Nagaraja Vinaya Babu from Tumkur, Karnataka
- PAC: Tumkur Trade Center Private Limited
- Open offer is not conditional upon minimum acceptance level
- No competing offer exists as of the date of this offer
- Current marketable lot is 1 share

## Regulatory Changes

This open offer is made in compliance with Regulations 3(1) and 4 of SEBI (SAST) Regulations, 2011, triggered by an underlying share purchase agreement (SPA).

## Compliance Requirements

- Public shareholders must respond to the offer through proper tendering process
- Form of Acceptance-cum-Acknowledgement must be submitted if accepting the offer
- If shares were recently sold, the Letter of Offer should be handed over to the purchaser
- All statutory approvals (if any become applicable) must be received before offer completion

## Important Dates

- Offer shares calculation basis: Tenth working day from closure of tendering period
- Specific tendering period dates to be announced separately
- All competing offers (if any) will open and close on the same date

## Impact Assessment

High impact on Pharmaids Pharmaceuticals shareholders as this represents a significant ownership change. The mandatory open offer provides exit opportunity for public shareholders at ₹62.15 per share. The acquisition may lead to change in management control and business strategy of the pharmaceutical company.